Skip to content

Screening versus multidimensional assessment of symptoms and psychosocial burden of cancer patients at the diagnosis of incurability

Screening versus multidimensional assessment of symptoms and psychosocial burden of cancer patients at the diagnosis of incurability

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00017774
Enrollment
504
Registered
2020-01-07
Start date
2019-10-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with an incurable cancer disease

Interventions

Group 1: screening, Patient will be asked short questionnaires (NCCN Distress Thermometer and IPOS) every 3-6 weeks Group 2: multidimensional assessment

Sponsors

Universitätsmedizin Göttingen Klinik für Palliativmedizin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: diagnosis of an incurable cancer disease

Exclusion criteria

Exclusion criteria: - underage - no written consent - can't give consent - not well enough to participate in the study

Design outcomes

Primary

MeasureTime frame
Quality of life after 6 months in both intervention arms using FACT-G, PHQ4, SCNS-34, NCCN distress thermometer.

Secondary

MeasureTime frame
- number of days spent in hospital and frequency of inclusion of emergency, palliative care and psychosocial care structures; Comparison of positive and negative screened patients with the actual inclusion of palliative care - Comparison of the two intervention arms, also comparing them with a "not-included 'historical'" control group (usual care) - Descriptive analysis of symptoms and stress in both intervention arms

Countries

Germany

Contacts

Public ContactStefanie Solar

UMG

screbel@med.uni-goettingen.de05513960559

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 10, 2026